FOLH1 and neoplasm: Semi-automatic PSMA contouring with an intraprostatic threshold of 30% of the intraprostatic SUVmax, used for gross tumor delineation, was proven to be technically feasible and would be relatively easy reproducible e.g. within a multi-center trial [32].